Filed under: Prostate Cancer , Drug , Clinical Trials , Research There's good news for prostate cancer patients who've had the disease spread to other parts of the body -- a new treatments, currently being tried out on hundreds of patients with promising results. The drug is called GVAX and it's referred to as a vaccine, although it doesn't work like most vaccines in the sense that it is administered after diagnosis and progression of the disease. According to this news story , GVAX works by adding prostate cancer cells to the body, but these new cells are unable to replicate. Several members of my family have battled prostate cancer to varying degrees of success, and I know that it's really widespread. So this is great news, and I hope GVAX is the miracle the prostate cancer is looking for. By the way, if you have prostate cancer, they're recruiting patients for their clinical trials. Read     Permalink     Email this     Linking Blogs     Comments